+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases



Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases



Annals of Surgical Oncology 15(6): 1661-1669



Although hepatic artery infusion chemotherapy (HAIC) of floxuridine (FUDR) for colorectal liver metastases (CLM) can produce high response rates, data concerning preoperative HAIC are scarce. The aim of this study was to assess the feasibility and results of liver resection after preoperative HAIC with FUDR. Between 1995 and 2004, 239 patients with isolated CLM received HAIC in our institution. Fifty of these patients underwent subsequent curative liver resection (HAIC group). Short- and long-term results of the HAIC group were compared with the outcomes of 50 patients who underwent liver resection for CLM without preoperative chemotherapy. Postoperative morbidity rate were comparable between the two groups. Overall disease-free survival at 1 and 3 years after hepatectomy were 77.5% and 57.5% in the HAIC group and 62.9% and 37% in the control group (P = .036). Overall survival from diagnosis of CLM at 1, 3, and 5 years were 97%, 59%, and 49% in the HAIC group versus 94%, 48%, and 35% in the control group (P = .097). When patients were stratified according to clinical-risk scoring (CRS) system, patients with more advanced disease at the time of liver resection (CRS > or = 3) had a median survival of 41 months in the HAIC group (n = 37) and 35 months in the control group (n = 34) (P = .031). HAIC of FUDR does not negatively affect the outcome of subsequent liver resection. Preoperative HAIC of FUDR may reduce liver recurrence rate and improve long-term survival in patients with more advanced liver disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055540453

Download citation: RISBibTeXText

PMID: 18373123

DOI: 10.1245/s10434-008-9882-5


Related references

Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 389-391, 2005

Clinical results of pharmacokinetic modulating chemotherapy (PMC) in combination with hepatic arterial 5FU infusion, continuous venous 5FU infusion and oral UFT as adjuvant chemotherapy after liver resection for hepatic colorectal metastases. Journal of Clinical Oncology 23(16_Suppl): 3665-3665, 2016

Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer. Cardiovascular and Interventional Radiology 31(1): 86-90, 2007

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy. Annals of Surgery 257(1): 114-120, 2013

Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. Journal of the American College of Surgeons 202(1): 100-111, 2006

Management of hepatic arterial infusion port following prophylactic regional chemotherapy in patients who have undergone curative resection of colorectal liver metastases. Surgery Today 33(9): 679-683, 2003

Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 1826-1829, 2000

Indication of prophylactic hepatic arterial-infusion chemotherapy after hepatic resection for liver metastases from colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1457-1460, 1996

Study of hepatic arterial infusion chemotherapy for prophylaxis of liver metastases of colorectal cancer after hepatic resection. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1497-1499, 1995

Indication for hepatic resection after hepatic arterial infusion chemotherapy for multiple liver metastases of colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 1834-1837, 2000

Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. American Journal of Surgery 166(6): 743, 1993

Efficacy of adjuvant hepatic arterial infusion chemotherapy following resection of colorectal liver metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1698-1701, 1999

Treatment of liver metastases from colorectal cancer--major hepatic resection and continuous hepatic arterial infusion chemotherapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Pt 2): 777-781, 1990

Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. Journal of Hepato-Biliary-Pancreatic Surgery 16(2): 137-144, 2009

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial. Bmc Cancer 19(1): 327, 2019